Good news for Lemtrada (alemtuzumab). The Peripheral and Central Nervous System Drugs Advisory Committee has recommended that the FDA approve alemtuzumab for the treatment of MS. As with any of our favorite concoctions there are serious risks, but the reduction in relapse rate seems to outweigh them.
http://www.medpagetoday.com/Neurology/MultipleSclerosis/42899?xid=nl_mpt_DHE_2013-11-14&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g530414d0r&userid=530414&email=***@****&mu_id=5653774
Kyle